AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Zeliang (Mark) Ma

Zeliang (Mark) Ma

Sun Yat Sen University - Guangzhou / China
Others
AD Scientific Index ID: 5859388
太阳森大学
person_outline Zeliang (Mark) Ma's MOST POPULAR ARTICLES
1-) Anlotinib enhances the antitumor activity of high‐dose irradiation combined with anti‐PD‐L1 by potentiating the tumor immune microenvironment in murine lung cancer Oxidative Medicine and Cellular Longevity 2022 (1), 5479491, 2022
2-) Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis Frontiers in Immunology 14, 1117448, 2023
3-) The optimal treatment for resectable esophageal cancer: a network meta-analysis of 6168 patients Frontiers in Oncology 11, 628706, 2021
4-) Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis Thoracic Cancer 12 (23), 3208-3215, 2021
5-) Higher lung and heart doses decrease early and long-term survival, respectively, in patients with non-small cell lung cancer undergoing postoperative radiation Advances in Radiation Oncology 8 (4), 101213, 2023